PIK3CA and posterior cortical atrophy: Notably, the combination of PARPi with PI3K inhibitors has been shown to effectively synergize to suppress tumorigenesis in human PCa cell lines and in a PTEN/Trp53-deficient mouse model of advanced PCa.